Four Antibiotics Impacted By Manufacturing Issues
Read about the biggest pharmaceutical developments from the past week in KFF Health News Prescription Drug Watch roundup.
FiercePharma:
Pfizer Halts 4 Antibiotics In India Due To Production Issues
Global drug giant Pfizer is warning physicians and clinicians in India to immediately stop using four of its antibiotics due to manufacturing issues at a contract producer. The warning covers Magnex, Zosyn, Magnamycin and Magnex Forte. (Keenan, 5/18)
ScienceDaily:
Previous Smallpox Vaccine Provides Immunity To Mpox
Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers report. (Karolinska Institutet, 5/23)
Reuters:
Purdue Pharma To Sell Consumer Business For $397 Mln
Bankrupt Purdue Pharma received a U.S. judge's permission on Tuesday to sell its consumer health business for $397 million to a subsidiary of Arcadia Consumer Healthcare. (Knauth, 5/23)
